Injective (INJ) is currently trading at $2.82, exhibiting a modest 24-hour change of 0.33%. The price has ranged from a low of $2.78 to a high of $2.83 within the past day, indicating low volatility with a daily range of just 0.05%.

The trading volume over the last 24 hours stands at approximately 26.22 million, which corresponds to a volume-to-market cap ratio of 9.31%. This level of trading activity suggests a healthy liquidity environment, although the overall price momentum remains subdued, given the slight upward movement in the daily change.

Analyzing the short-term moving averages, the 8, 13, and 21-period SMAs are showing positive trends, indicating potential support at $2.81, $2.81, and $2.80, respectively. Conversely, the 55-period SMA at $2.79 and the 144-period SMA at $2.84 reflect minor bearish sentiment, especially with the latter showing a decrease of 0.75%.

The Relative Strength Index (RSI) indicates a strong short-term momentum at 65 for the 1-hour timeframe, suggesting upward potential. However, the 7-day RSI is neutral at 51, which coupled with a negative price change over the past week (-2.53%) and two-week (-9.34%), points to a broader consolidation phase.

Injective's all-time high was significantly higher at $52.62, achieved in March 2024, which indicates considerable long-term growth potential but also highlights the current price's significant retracement. The sharp declines over the past month (-8.07%) further emphasize the necessity for cautious trading strategies in the near term.

Considering the current price action, momentum indicators, and broader price history, the recommendation for Injective (INJ) is to **Hold**. The short-term bullish signals are tempered by recent bearish trends and overall market consolidation, suggesting a wait-and-see approach until more definitive upward momentum is established.